Modulation of the inflammatory response by increasing fetal wound size or interleukin-10 overexpression determines wound phenotype and scar formation

Wound Repair and Regeneration

Volumn 22, Issue 3, 2014, Pages 406-414

  Morris, Michael W ^a   Allukian, Myron ^b   Herdrich, Benjamin J ^b   Caskey, Robert C ^b   Zgheib, Carlos ^c,d   Xu, Junwang ^c,d   Dorsett Martin, Wanda ^a   Mitchell, Marc E ^a   Liechty, Kenneth W ^d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEMOURS CHILDREN S HOSPITAL   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKINE; INTERLEUKIN 10; LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETUS; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCAR FORMATION; SHEEP; SKIN INJURY; TISSUE REGENERATION; TRANSGENE; WOUND HEALING; ANIMAL; EMBRYOLOGY; FEMALE; FIBROBLAST; INJURY; METABOLISM; PATHOLOGY; PREGNANCY; REGENERATION; SCAR; SKIN;

ANIMALS; CICATRIX; FEMALE; FETUS; FIBROBLASTS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; PHENOTYPE; PREGNANCY; REGENERATION; SHEEP; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84901014488     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12180     Document Type: Article

References (40)

1. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW, etal. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008; 128: 1852-1860.
2. Liechty KW, Adzick NS, Crombleholme TM,. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 2000; 12: 671-676.
3. Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N, etal. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998; 91: 258-265.
4. Keever-Taylor CA, Witt PL, Truitt RL, Ramanujam S, Borden EC, Ritch PS,. Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. J Immunother Emphasis Tumor Immunol 1996; 19: 231-243.
5. Martin P,. Wound healing-aiming for perfect skin regeneration. Science 1997; 276: 75-81.
6. Kuhlmann UC, Chwieralski CE, Reinhold D, Welte T, Buhling F,. Radiationinduced matrix production of lung fibroblasts is regulated by interleukin-8. Int J Radiat Biol 2009; 85: 138-143.
7. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, etal. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-1480.
8. Kossi JA, Salminen PT, Laato MK,. Surgical work load and cost of postoperative adhesion-related intestinal obstruction: importance of previous surgery. World J Surg 2004; 28: 666-670.
9. Williams F, Knapp D, Wallen M,. Comparison of the characteristics and features of pressure garments used in the management of burn scars. Burns 1998; 24: 329-335.
10. Wells CD, Murrill WB, Arguedas MR,. Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease. Dig Dis Sci 2004; 49: 453-458.
11. Occleston NL, O'Kane S, Laverty HG, Cooper M, Fairlamb D, Mason T, etal. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring. Wound Rep Regen 2011; 19 (Suppl. 1): s38-s48.
12. Longaker MT, Adzick NS, Hall JL, Stair SE, Crombleholme TM, Duncan BW, etal. Studies in fetal wound healing, VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid. J Pediatr Surg 1990; 25: 430-433.
13. Adzick NS, Harrison MR, Glick PL, Beckstead JH, Villa RL, Scheuenstuhl H, etal. Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 1985; 20: 315-319.
14. Krummel TM, Nelson JM, Diegelmann RF, Lindblad WJ, Salzberg AM, Greenfield LJ, etal. Fetal response to injury in the rabbit. J Pediatr Surg 1987; 22: 640-644.
15. Gordon A, Kozin ED, Keswani SG, Vaikunth SS, Katz AB, Zoltick PW, etal. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation. Wound Repair Regen 2008; 16: 70-79.
16. Liechty KW, Crombleholme TM, Cass DL, Martin B, Adzick NS,. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998; 77: 80-84.
17. Liechty KW, Kim HB, Adzick NS, Crombleholme TM,. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 2000; 35: 866-872, discussion 872-3.
18. Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS,. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994; 171: 55-59.
19. Cass DL, Bullard KM, Sylvester KG, Yang EY, Longaker MT, Adzick NS,. Wound size and gestational age modulate scar formation in fetal wound repair. J Pediatr Surg 1997; 32: 411-415.
20. Herdrich BJ, Danzer E, Davey MG, Bermudez DM, Radu A, Zhang L, etal. Fetal tendon wound size modulates wound gene expression and subsequent wound phenotype. Wound Rep Regen 2010; 18: 543-549.
21. Adzick NS, Lorenz HP,. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994; 220: 10-18.
22. Donello J, Loeb JE, Hope TJ,. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 1998; 72: 5085-5092.
23. Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J, etal. The HIV-1 DNA flap stimulates HIV vector mediated cell transduction in the brain. Nat Biotechnol 2001; 19: 446-450.
24. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW,. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004; 122: 131-139.
25. Masson P,. Trichrome staining and their preliminary techniques. Bull Int Assoc Med 1929; 12: 75-90.
26. Watanabe T, Miura T, Degawa Y, Fujita Y, Inoue M, Kawaguchi M, etal. Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR. Cancer Cell Int 2010; 10: 1-12.
27. Hillegass JM, Shukla A, MacPherson MB, Bond JP, Steele C, Mossman BT,. Utilization of gene profiling and proteomics to determine mineral pathogenicity in a human mesothelial cell line (LP9/TERT-1). J Toxicol Environ Health A 2010; 73: 423-436.
28. Ferguson MW, O'Kane S,. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Phil Trans R Soc Lond 2004; 359: 839-850.
29. Ferguson MW, Duncan J, Bond J, Bush J, Durani P, So K, etal. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2009; 373: 1264-1274.
30. Murray PJ,. The primary mechanism of the IL-10 regulated anti-inflammatory response is to selectively inhibit transcription. PNAS 2005; 102: 8686-8691.
31. Fortunato SJ, Menon R, Swan KF, Lombardi SJ,. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation. Am J Obstet Gynecol 1996; 175 (4 Pt 1): 1057-1065.
32. Fortunato SJ, Menon R, Lombardi SJ,. The effect of transforming growth factor and interleukin-10 on interleukin-8 release by human amniochorion may regulate histologic chorioamnionitis. Am J Obstet Gynecol 1998; 179 (3 Pt 1): 794-799.
33. Elgert KD, Alleva DG, Mullins DW,. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 1998; 64: 275-290.
34. Beredjiklian PK, Favata M, Cartmell JS, Flanagan CL, Crombleholme TM, Soslowsky LJ,. Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep. Ann Biomed Eng 2003; 31: 1143-1152.
35. Mast BA, Diegelmann RF, Krummel TM, Cohen IK,. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993; 13: 441-446.
36. Mast BA, Flood LC, Haynes JH, DePalma RL, Cohen IK, Diegelmann RF, etal. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix 1991; 11: 63-68.
37. Hu M, Sabelman EE, Cao Y, Chang J, Hentz VR,. Three-dimensional hyaluronic acid grafts promote healing and reduce scar formation in skin incision wounds. J Biomed Mater Res B Appl Biomater 2003; 67: 586-592.
38. Caskey RC, Allukian M, Lind RC, Herdrich BJ, Xu J, Radu A, etal. Lentiviral-mediated over-expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair. Cell Tissue Res 2013; 351: 117-125.
39. Colwell AS, Longaker MT, Lorenz HP,. Fetal wound healing. Front Biosci 2003; 8: s1240-1248.
40. Sullivan KM, Lorenz HP, Meuli M, Lin RY, Adzick NS,. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 1995; 30: 198-202, discussion 202-3.